Haleon plc filings document foreign private issuer disclosures for a global consumer health company whose American depositary shares trade under HLN. Form 6-K reports cover current information such as trading statements, ordinary-share repurchases for cancellation, total voting rights and capital, and annual general meeting poll results.
The filing record also includes debt-market disclosures, including listing particulars for the Euro Medium Term Note programme of Haleon UK Capital plc and Haleon Netherlands Capital B.V. guaranteed by Haleon. Governance and capital-structure disclosures address directors' remuneration, board elections, dividend approvals, special resolutions, ordinary shares, treasury shares, voting rights and shareholder notification thresholds.
Haleon plc announced the purchase and cancellation of 2,975,063 ordinary shares of each under the second tranche of its buyback programme announced 31 July 2025. The trades were executed on 26-27 August 2025 on the London Stock Exchange CBOE (UK)/CXE with individual trade prices reported and a weighted figure of 359.1984 shown in the announcement. After settlement the company's registered share capital is 8,966,351,142 ordinary shares of each, of which 3,880,205 are held as treasury shares, leaving 8,962,470,937 ordinary shares with voting rights. The announcement directs readers to a full trade breakdown and to the company's investor website for details.
Haleon plc announced the purchase and cancellation of 1,369,903 ordinary shares under the second tranche of its share buyback programme. The trades were executed on the London Stock Exchange/CBOE (UK)/CXE on 22 August 2025 and a full breakdown of individual trades is linked in the release. After settlement, the company's registered share capital is 8,969,326,205 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares, leaving 8,965,446,000 ordinary shares with voting rights. The announcement clarifies where the trade details and the announcement are available online.
Haleon plc announced the purchase and cancellation of 175,642 ordinary shares of of each as part of the second tranche of its share buyback programme announced on 31 July 2025. After settlement, Haleon registered share capital stands at 8,970,696,108 ordinary shares of each, of which 3,880,205 are held as treasury shares, leaving 8,966,815,903 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided link and on the Company's investor website. This announcement relates solely to the executed tranche of the buyback programme and the resulting share capital figures.
Haleon plc announced the purchase and cancellation of 930,345 ordinary shares under the second tranche of its buyback programme. Reported trade prices ranged between £360.90 and £367.00 with a reported volume-weighted average price of £363.4411. After settlement the company states its registered share capital is 8,970,871,750 ordinary shares, of which 3,880,205 are held as treasury, leaving 8,966,991,545 ordinary shares with voting rights. The announcement points shareholders to a full trade breakdown and notes the release does not constitute an offer for securities.
Haleon plc filed a Form 6-K publishing a TR-1 notification showing major holdings in the Company. The notice reports 423,379,327 direct voting rights (4.72%) and additional financial instruments totaling 26,420,926 voting rights plus equity swaps of 193,460 rights, amounting to 5.01% of voting rights through financial instruments. The disclosure identifies Wellington Management Group LLP and related controlled undertakings as the reporting chain that holds the 5.01% position. The TR-1 was published around 19-20 August 2025 and includes nominee holdings and a full chain of controlled undertakings for the reporting entity.
Haleon plc reports the purchase and cancellation of 1,504,400 ordinary shares of each under the second tranche of its share buyback programme announced 31 July 2025. Trades executed on 18 August 2025 via London Stock Exchange CBOE (UK)/CXE at an average price of 358.0459 per share. After settlement, registered share capital is 8,971,802,095 ordinary shares, with 3,880,205 held as treasury shares, leaving 8,967,921,890 ordinary shares with voting rights. A full breakdown of individual trades is available via the provided RNS link and on the company website.
Haleon plc reports the purchase and cancellation of 1,600,000 ordinary shares of £0.01 each as part of the second tranche of its buyback programme announced 31 July 2025. After settlement, registered share capital is 8,973,306,495 ordinary shares, with 3,880,205 held as treasury shares, leaving 8,969,426,290 voting ordinary shares. A full breakdown of individual trades is available via the provided RNS link and on the Company website. The announcement states it does not constitute an offer for securities.
Haleon plc announced the purchase and cancellation of 1,399,293 ordinary shares of each under the second tranche of its share buyback programme announced 31 July 2025. Trades executed on 14 August 2025 on the London Stock Exchange/CBOE UK totalled 1,399,293 shares at an average price of 58.7136. After settlement, registered share capital is 8,974,906,495 ordinary shares, of which 3,880,205 are treasury shares, leaving 8,971,026,290 ordinary shares with voting rights for disclosure threshold purposes. A full trade breakdown is available via the provided RNS link and the company's investor website.
Haleon has completed a tranche of its announced share buyback, purchasing 830,000 ordinary shares for cancellation on 13 August 2025 at a volume-weighted average price of 356.7308p. The purchases on the London Stock Exchange ranged between 354.7000p and 358.6000p.
After settlement the company reports a registered share capital of 8,976,305,788 ordinary shares, of which 3,880,205 are held in treasury, leaving 8,972,425,583 voting shares. A full trade breakdown is available from the company’s announcement link and on its investor website.
Haleon plc announced the purchase and cancellation of 1,400,000 ordinary shares of \u00A3 .01 each under the second tranche of its buyback programme. The purchases occurred on 12 August 2025 on the London Stock Exchange with a highest price of 356.1000p, lowest of 353.2000p and a volume weighted average price of 354.8037p.
After settlement the company reports registered share capital of 8,977,135,788 ordinary shares, of which 3,880,205 are held as treasury shares, leaving 8,973,255,583 ordinary shares with voting rights. The announcement includes a breakdown of individual trades under the Market Abuse Regulation and provides links for shareholders to verify holdings for FCA notification thresholds.